Recently, several GPCRs involved in the development of insulin resistance and pancreatic β-cell dysfunction, such as GPR119, GPR146, GPR40, GPR120, and TGR5, have received attention as targets for therapeutic interventions in diabetic patients [54,55,56]. This evidence concerns the gene GPR146 and Insulin resistance.